Tajikistan received 1,500,100 doses of Moderna vaccine donated to the COVAX Facility by the United States Government. This shipment is part of the 80 million doses of vaccine that the President of the United States committed in May from the U.S. vaccine supply, of which approximately 41 million doses are shared through COVAX, to support global needs.
U.S. Ambassador to Tajikistan John Mark Pommersheim underscored, “This donation of 1.5 million doses of the Moderna vaccine will save lives. My family and I also received the Moderna vaccine, and I encourage everyone who can get vaccinated to do so. Vaccination not only protects your own health but can also save the lives of others. We will continue to assist the people of Tajikistan to defeat this virus, and we will get through this crisis together!”
Vaccination not only protects your own health but can also save the lives of others.
The United States is committed to working with partners across the globe to end the public health and economic effects of this pandemic. Through USAID, the United States has contributed $2 billion to Gavi, the Vaccine Alliance, to support the purchase and delivery of COVID-19 vaccines to 92 low- and middle-income countries, and we plan to commit another $2 billion by 2022, making the United States the largest financial donor to COVAX. This contribution to COVAX is supporting equitable access to COVID-19 vaccines for the world’s most vulnerable and at-risk populations, including frontline health care workers. In Tajikistan, in addition to this vaccine donation, the United States has contributed over USD 9 million in COVID-19 related assistance to strengthen partner capacities in Tajikistan to fight against COVID-19.
“UNICEF and UN Family welcome donation of the COVID-19 vaccine by the United States Government via COVAX mechanism which has arrived in Tajikistan today,” said Osama Makkawi Khogali, the UNICEF Representative in Tajikistan. “No one is safe unless all of us are safe. Vaccines donated by US Government will support the already initiated immunization campaign in Tajikistan, providing equitable access to vaccination for priority target groups. We thank our partners from the US Government."
No one is safe unless all of us are safe.
In addition to today’s shipment, Tajikistan has previously received 192,000 doses of the AstraZeneca vaccine via the COVAX Facility. The COVAX Facility is co-led by the World Health Organization (WHO), Coalition for Epidemic Preparedness and Innovations (CEPI), GAVI - the Vaccine Alliance, and UNICEF as a key delivery partner.
Moderna’s COVID-19 vaccine received a WHO Emergency Use Listing (EUL) on 30 April. On 3 May, the COVAX Facility announced that it had signed an Advance Purchase Agreement to secure access to 34 million doses of COVID-19 vaccines from Moderna in the fourth quarter of 2021 and up to 466 million doses in 2022.